lancet-header

Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.

A Novel Ileocolonic Crohn's Staging Tool: The Development and Validation of an Evidence-Based, End-User Informed Radiological Decision-Aid

66 Pages Posted: 16 Nov 2018

See all articles by Pritesh Morar

Pritesh Morar

St Mark's Hospital - Department of Colorectal Surgery; Imperial College London - Department of Surgery and Cancer

Karin Wasmann

University of Amsterdam, Amsterdam Medical Center, Department of Surgery

Ana C.T. Fareleira

Centro Hospitalar S. Joao

Kapil Sahnan

St Mark's Hospital

Samuel O. Adegbola

St Mark's Hospital

Evgenia Mainta

St Mark's Hospital

Rajapandian Ilangovan

St Mark's Hospital

Sonal Arora

Imperial College London - Department of Surgery and Cancer

Nick Sevdalis

Imperial College, London

Kanyada Koysombat

St Mark's Hospital

Ailsa Hart

St Mark's Hospital

David Burling

St Mark's Hospital

Cathryn Edwards

South Devon NHS Foundation Trust

Janindra Warusavitarne

St Mark's Hospital

Arun Gupta

St Mark's Hospital

Willem Bemelman

University of Amsterdam

Omar Faiz

St Mark's Hospital

More...

Abstract

Background: Consensus guidelines emphasise the importance of multidisciplinary team driven care for patients with complex Crohn's disease. There are, however, no clear definitions of complexity beyond the presence or absence of pre-operative intra-abdominal sepsis. This study aims to develop a staging instrument (The St Mark's - Amsterdam tool) for complex ileocolonic Crohn's disease based upon best evidence and end-user expert opinion. The secondary aim is to investigate validation and reliability evidence for this staging tool.

Methods: Items for the staging tool were developed using a literature review and semi-structured interviews. Validity was tested using pre-operative, peri-operative and post-operative outcome measures which were reviewed against intra-operative and histopathologically and radiologically assigned stages. Reliability was tested against intra-operative and histopathologically assigned stages using magnetic resonance enterography (MRE) and computer tomographic enterography (CTE), which were used to provide an objective pre-operative stage for patients who have undergone ileocolonic resection.

Findings: A 4-stage tool was derived including items detailing ileocolonic radiological disease: 1) predominantly inflammatory stricture; 2) predominantly fibrotic stricture; 3) fistulating; and 4) intra-abdominal abscess/collection. Validity testing demonstrated a greater proportions of pre-operative anaemia, concomitant sigmoidectomy and pre-emptive stoma formation, and/or post-operative intra-abdominal septic complications and/or Clavien-Dindo≥3, with increasing intra-operative and histopathologically and pre-operative radiological stage (p<0.05). Good reliability was demonstrated between pre-operative radiological stages and intra-operative and histopathologically assigned stages (R=0.8; p<0.001).

Interpretation:This novel staging tool has been validated to show greater morbidity with increasing stage severity. It can reliably be used to pre-operatively stage patients, and inform surgical decision-making and estimate morbidity. It also allows for appropriate case mix adjustment from a research and outcomes reporting. Further multi-center prospective validation of this tool is required for both clinical and research purposes.

Funding Statement: Morar, Sevdalis, Edwards and Faiz were funding by the Health Service Award, Crohn’s And Colitis UK (IBDHS/13/1). Nick Sevdalis’ research is funded by the NIHR via the ‘Collaboration for Leadership in Applied Health Research and Care South London’ (CLAHRC South London) at King's College Hospital NHS Foundation Trust, London, UK. Sevdalis is also part of King's Improvement Science, which is part of the NIHR CLAHRC South London and comprises a specialist team of improvement scientists and senior researchers based at King’s College London. King's Improvement Science is funded by King’s Health Partners (Guy’s and St Thomas’ NHS Foundation Trust, King’s College Hospital NHS Foundation Trust, King’s College London and South London and Maudsley NHS Foundation Trust), Guy’s and St Thomas’ Charity, the Maudsley Charity and the Health Foundation. Nick Sevdalis is also funded by the South London and Maudsley NHS Foundation Trust. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Edwards was funded by the South Devon Healthcare Charitable Fund (1052232).

Declaration of Interests: NS is the Director of London Safety and Training Solutions Ltd, which provides quality and safety training and advisory services on a consultancy basis to healthcare organization globally.

Ethics Approval Statement: Institutional approval from the local NHS hospital research and development committee was obtained (11/2014) prior to data collection. Data were obtained by cross-referencing two prospectively maintained databases within our institution from over a 10-year period [January 1, 2005 to January 1, 2015].

Keywords: Radiology, MRE, CTE, Crohn's Disease, Ileocolonic, Ileocaecal, Surgery

Suggested Citation

Morar, Pritesh and Wasmann, Karin and Fareleira, Ana C.T. and Sahnan, Kapil and Adegbola, Samuel O. and Mainta, Evgenia and Ilangovan, Rajapandian and Arora, Sonal and Sevdalis, Nick and Koysombat, Kanyada and Hart, Ailsa and Burling, David and Edwards, Cathryn and Warusavitarne, Janindra and Gupta, Arun and Bemelman, Willem and Faiz, Omar, A Novel Ileocolonic Crohn's Staging Tool: The Development and Validation of an Evidence-Based, End-User Informed Radiological Decision-Aid (March 11, 2018). Available at SSRN: https://ssrn.com/abstract=3284185 or http://dx.doi.org/10.2139/ssrn.3284185

Pritesh Morar (Contact Author)

St Mark's Hospital - Department of Colorectal Surgery ( email )

London
United Kingdom

Imperial College London - Department of Surgery and Cancer ( email )

Praed Street
London, NW1 1SQ
United Kingdom

Karin Wasmann

University of Amsterdam, Amsterdam Medical Center, Department of Surgery ( email )

Netherlands

Ana C.T. Fareleira

Centro Hospitalar S. Joao

Porto
Portugal

Kapil Sahnan

St Mark's Hospital

Harrow
United Kingdom

Samuel O. Adegbola

St Mark's Hospital

Harrow
United Kingdom

Evgenia Mainta

St Mark's Hospital

Harrow
United Kingdom

Rajapandian Ilangovan

St Mark's Hospital

Harrow
United Kingdom

Sonal Arora

Imperial College London - Department of Surgery and Cancer

Praed Street
London, NW1 1SQ
United Kingdom

Nick Sevdalis

Imperial College, London ( email )

United Kingdom

Kanyada Koysombat

St Mark's Hospital

Harrow
United Kingdom

Ailsa Hart

St Mark's Hospital

Harrow
United Kingdom

David Burling

St Mark's Hospital

Harrow
United Kingdom

Cathryn Edwards

South Devon NHS Foundation Trust

Torbay
United Kingdom

Janindra Warusavitarne

St Mark's Hospital

Harrow
United Kingdom

Arun Gupta

St Mark's Hospital

Harrow
United Kingdom

Willem Bemelman

University of Amsterdam

Spui 21
Amsterdam, 1018 WB
Netherlands

Omar Faiz

St Mark's Hospital

Harrow
United Kingdom